Kinetics and Thermodynamics in Drug Discovery: May 22, 2014
Big Lecture Hall, Department of Chemistry
University of Basel, St. Johanns-Ring 19
May 22, 2014, 13.30-17.45
This year's annual mini-symposium organized by the Division of Medicinal Chemistry & Chemical Biology of the Swiss Chemical Society is dedicated to the topic of Kinetics and Thermodynamics in Drug Discovery.
This free event is gathering five globally renowed experts in the field that will showcase the importance of this topic in drug discovery.
Program
| 13:30–13:35 | Introduction |
| 13:35–14:20 |
Gerhard Klebe, University of Marburg Correlation of Structure, Thermodynamics and Molecular Dynamics to Better Understand Drug Binding |
| 14:20–15:05 |
David Swinney, iRND3 Application of binding kinetics to drug discovery |
| 15:05–15:30 | Coffee Break |
| 15:30–16:15 |
Göran Dahl, AstraZeneca Pharmacokinetics and the drug-target residence time concept |
| 16:15–17:00 |
David Sykes, Novartis Institutes for Biomedical Research Exploring the relationship betweenb2 adrenoceptor drug binding affinity/kinetic constants and physicochemical parameters |
| 17:00–17:45 |
Russel Petter, Celgene Design and Optimization of Targeted Covalent Inhibitors |
Contact
Herr Dr. Nikolaus Stiefl
Novartis Pharma AG
Forum1, Novartis Campus
4056 Basel
David Spichiger, SCS
03.02.2014
Call for nominations: EFMC 2014 Awards
The awards will be conferred on the occasion of the XXIII EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC), to be held in Lisbon, Portugal, September 7-11, 2014
|
For the advancement of medicinal chemistry and the development of international organisational structures in Medicinal Chemistry. The Award will be given for outstanding achievements in the field of Medicinal Chemistry.
|
|
To acknowledge and recognize outstanding research in the field of Medicinal Chemistry in its broadest sense by a young scientist. This Award has been established with the support of UCB Pharma.
|
|
The Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery |
To encourage innovation and investigation in technological development related to drug discovery, this Award established with the support of Prous Institute will be given for the discovery, evaluation or use of new technologies.
|
Nominations for these Awards consist of a nomination letter, a brief CV, including a list of selected publications and two supporting letters. Self-nominations are also accepted. The nominations should be submitted to the Chairman of the Juries, Dr Hans Ulrich Stilz, President of EFMC, c\o EFMC Administrative Secretariat, Rue Michel de Ghelderode 33/2, 1348, Louvain-la-Neuve, Belgium. Fax: +32 10 45 97 19 E-mail: .
Please visit www.efmc.info for more information and Awards regulations.
Conferences in Dubai 2014. Discount for SCS Members
In February 2014 four conferences in the field of drug discovey and medicinal chemistry take place in Dubai. As an SCS member you profit from a 10% discount on the registration fee. Please refer to this message and your status as an SCS member when registering.
It is our great pleasure to announce the latest editions of our very successful series of conferences; the “6th International Conference on Drug Discovery and Therapy” and the “3rd Biotechnology World Congress” in Dubai UAE. This time there will be two new events taking place in parallel to these conferences, namely the “1st Global Cardiovascular Translational Medicine Conference” and the “1st Global Diabetes and Obesity Translational Medicine Conference” with Dr. Ferid Murad, Nobel Laureate and Prof. Atta-ur-Rahman, FRS as the conferences Co-Presidents. These events are being organized in collaboration with the Higher Colleges of Technology, UAE. The dates of the four events are given below:
- 6th International Conference on Drug Discovery and Therapy
February 10th - 12th, 2014 - 3rd Biotechnology World Congress
February 10th - 12th, 2014 - 1st Global Cardiovascular Translational Medicine Conference
February 12th - 13th, 2014 - 1st Global Diabetes and Obesity Translational Medicine Conference
February 12th - 13th, 2014
These events will be unique in promoting the translational nature of modern biomedical, biotech and pharmaceutical research, with both scientists and clinicians associated with scientific and medical research and application, attending. The conferences will not only feature recent findings from leading industrial, clinical and academic experts in the field, in the form of lectures and posters but are also aimed to provide a platform to all the leading clinicians.
Sincerely yours,
Q.O. Malik
Corporate Manager
Eureka Science
David Spichiger, SCS
15.10.2013
Application for the International BioChamp 2012
The Novartis International Biotechnology Leadership Camp (BioCamp) brings together selected top students from science and business universities from around the world.
EFMC: 6th short course on medicinal chemistry.
Improving Compound Quality: Physical Chemistry and DMPK Properties in Drug Discovery.
October 21-24, 2012, Oegstgeest, The Netherlands
Registration Deadline: September 14, 2012
In modern drug discovery, it is important that the Medicinal Chemist understands how to balance potency and ADME properties in order to provide high quality compounds for progression to clinical studies.
This short course will be a mixture of talks and worked exercises designed to further the understanding of DMPK. The course will include: Outlines of the key DMPK in vitro assays: physicochemistry for ADME; Oral drug absorption; Fundamentals of drug distribution; drug metabolizing enzymes; drug transport proteins; basic PK principles and human PK prediction; PKPD relationships.
Contact:
Symposium Secretariat
LD Organisation
Tel : +32 10 45 47 77
Fax : +32 10 45 97 19
e-mail:
More information:
http://www.ldorganisation.com/antfichiers/13382744446th_Short_Course_-_course_outline.pdf
David Spichiger, SCS
11.09.2012
Page 276 of 298